Atosiban(CAS: 90779-69-4)

Atosiban (CAS: 90779-69-4) is a synthetic oxytocic medication primarily used to manage uterine contractions. It functions as a potent inhibitor of oxytocin receptors, helping to reduce the risk of preterm labor. Chemically, it is known as 4-(2-[[2-(2-ethoxyethoxy)ethoxy]carbonyl]amino)phenyl]morpholine, and it is characterized by its selective antagonism of the oxytocin receptor, making it an effective tocolytic agent in obstetrics.

Atosiban (CAS: 90779-69-4) is mainly used in pharmaceuticals as a tocolytic drug to delay preterm labor. It is also used in research for studying uterine contractions and oxytocin receptor interactions. In clinical practice, it helps manage conditions like premature contractions and is sometimes used off-label for other uterine-related issues. Its applications are particularly relevant in obstetrics and gynecology.

Atosiban (CAS: 90779-69-4) is generally considered safe when used as directed in medical settings. It has a favorable safety profile with minimal systemic absorption, reducing the risk of side effects. However, it should be handled with care, and healthcare professionals should follow guidelines to ensure proper use. Safety standards are in place to monitor its application in human and veterinary medicine.

Atosiban (CAS: 90779-69-4) should be stored in a cool, dry place away from direct light. It is typically kept at room temperature (15–30°C) and protected from moisture. Proper storage ensures the stability and potency of the compound. Always store in a sealed container to prevent degradation and maintain quality over time.